A complete application in a minute
Tailored resume and cover letter, ready to send.
Oxford Biomedica is seeking a UK Revenue Margin Manager to join the Finance team. You will own UK revenue and margin accounting, drive financial controls, reporting and business partnering to support strategic decisions.
The role requires ACA/ACCA/CIMA qualification, strong cost and revenue accounting knowledge, and proven leadership. You will partner with UK stakeholders and contribute to budgeting, forecasting and compliance processes.
Select how often (in days) to receive an alert:
AtOXB, our people are at the heart of everything we do. We’re on a mission to enable life-changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day:Responsible, Responsive, Resilient, and Respectful.
We’re currently recruiting for aUK Revenue Margin Manager to join our Finance team. In this role, you willtake ownership of UK revenue and margin accounting, financial control, reporting, and business partnering activities, playing a key part in advancing our mission and making a real difference.
OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world.
One of the original pioneers in cell and gene therapy, OXB has 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. OXB’s world-class capabilities range from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
OXB offers a vast number of technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the TetraVecta™ system), a dual-plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines.
OXB, a FTSE250 and FTSE4Good constituent, is headquartered in Oxford, UK. It has development and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France, Bedford MA, and Durham NC, US.
We want you to feel inspired every day. At OXB, we’re future-focused and growing fast. We succeed together—through passion, commitment, and teamwork.
The closing date for applications is 20th November 2026.
Our vacancies are typically advertised for a minimum of 10 working days. Once a vacancy closes, it may take a few days for us to provide an update while our Talent Acquisition team and hiring managers review all applications. Every application is reviewed manually by our recruitment team and hiring managers. We do not use AI to screen CVs or make shortlisting decisions.